October 2025
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
May 2026
The global cancer biological therapy market size is expected to increase from USD 124.44 billion in 2025 and is predicted to reach at USD 266.75 billion by 2035, with a solid CAGR of 7.99%.
April 2026
The cancer gene therapy market size was estimated at USD 4.14 billion in 2025 and is projected to hit around USD 22.32 billion by 2035 with a CAGR of 18.35%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
February 2026
The cancer immunotherapy market size is calculated at USD 136.39 billion in 2025 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 6.31 billion in 2024, with a CAGR of 27.92%.
September 2025
The oncology CDMO market is expanding rapidly, fueled by rising cancer prevalence, growing demand for advanced therapies like ADCs and cell & gene therapies, and the increasing need for specialized outsourcing services.
July 2025
Explore the oncology combination therapy market, driven by rising cancer prevalence, improved treatment efficacy through drug combinations, and advancements in personalized medicine.
June 2026
The global phage therapy market size is evaluated at USD 1.29 billion in 2025 and is predicted to hit around USD 1.92 billion by 2035, growing at a CAGR of 4.06%.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global oncolytic virus-based gene therapy market is growing rapidly as viral vectors are engineered to selectively target and destroy cancer cells.
June 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
June 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
June 2026
The global neoantigen cancer vaccine market size is evaluated at USD 475.68 million in 2025 and is predicted to hit around USD 2,023.79 million by 2035, growing at a CAGR of 15.58%.
June 2026
The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.
June 2026
The global pharmaceutical CDMO for formulations market size is accounted to hit around USD 103.33 billion by 2035, increasing from USD 48.85 billion in 2025, with a CAGR of 7.78%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
June 2026
The global oncolytic virus therapy market size is evaluated at USD 3.71 billion in 2025 and is predicted to hit around USD 12.31 billion by 2035, growing at a CAGR of 12.74%.
June 2026
The US brachytherapy market size was evaluated at USD 345.22 million in 2025 and is predicted to hit around USD 699.86 million by 2035, growing at a CAGR of 7.32%.
June 2026
The global proton therapy market size surpassed USD 648.64 million in 2025 and is projected to surpass around USD 2,229.88 million by 2035 with a CAGR of 13.14%.
June 2026
The global AI-integrated CDMO process optimization market is growing as contract manufacturers adopt AI to streamline drug development and manufacturing workflows.
June 2026
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
June 2026
The global estrogen replacement therapy market size was evaluated at USD 11.75 billion in 2025 and is predicted to hit around USD 20.49 billion by 2035, growing at a CAGR of 5.72%.
June 2026
The global skin cancer diagnostic market size is evaluated at USD 8.97 billion in 2025 and is predicted to hit around USD 14.60 billion by 2035, with a CAGR of 4.99%.
June 2026
The global AAV gene therapy market size was evaluated at USD 2.85 billion in 2025 and is predicted to hit around USD 27.41 billion by 2035, with a CAGR of 25.39%.
June 2026
The US CAR T-cell therapy market size was evaluated at USD 2,299.97 million in 2025 and is predicted to hit around USD 11,510.04 million by 2035, growing at a CAGR of 17.47%.
June 2026
The solid tumor cancer treatment market size was valued at USD 5.64 billion in 2025 and is projected to hit around USD 9.14 billion by 2035 with a CAGR of 4.95%.
June 2026
The global salt therapy market size is projected to surpass around USD 20.57 billion by 2035 increasing from USD 8.59 billion in 2025, with a CAGR of 9.12%.
June 2026
The global oral cancer rapid test kit market size is estimated to hit around USD 3.94 billion by 2035 increasing from USD 2.38 billion in 2025, with a CAGR of 5.17%.
June 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com